1. Researchers for this meta-analysis investigated GLP-1 RAs and risk of NAION.
2. GLP-1 RA use was associated with reduction of major cardiovascular events, but there may be links  NAION, obesity, diabetes, and obstructive sleep apnea.
3. The researchers described the need for further research on the safety of GLP-1 RAs for obese or diabetic patients who have an increased baseline risk of NAION.

Source: Diabetes, Obesity, and Metabolism